Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

741
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
741
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

560
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
560
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

436
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
436
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

250
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
250
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

285
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
285

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: The role of autophagy in infectious diseases, volume II.

Frontiers in cellular and infection microbiology·2026
Same author

A multinational Delphi consensus on tuberculosis screening of migrants in Europe.

ERJ open research·2025
Same author

Vesicular transport in the autophagic route: RAB GTPases as pivotal regulators of autophagy.

The Biochemical journal·2025
Same author

Tick Extracellular Vesicles Alter Epidermal Keratinocyte Function.

The Journal of investigative dermatology·2025
Same author

Corrigendum to SLAMF7 and SLAMF8 receptors shape human plasmacytoid dendritic cell responses to intracellular bacteria.

The Journal of clinical investigation·2025
Same author

A new role of RAB21 and VARP in autophagy and autophagic exocytosis of ATP.

Autophagy reports·2025

Related Experiment Video

Updated: Oct 31, 2025

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.8K

PGE2 displays immunosuppressive effects during human active tuberculosis.

Joaquín Miguel Pellegrini1,2, Candela Martin1,2, María Paula Morelli1,2

  • 1Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales , Universidad de Buenos Aires, Intendente Güiraldes 2160, Pabellón II, 4°piso, Ciudad Universitaria (C1428EGA), Buenos Aires, Argentina.

Scientific Reports
|July 1, 2021
PubMed
Summary

Prostaglandin E2 (PGE2) suppresses the human immune response to tuberculosis (TB) by reducing immune cell activity and promoting autophagy. This suggests PGE2 could be a therapeutic target for improving anti-TB treatments.

More Related Videos

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.2K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.0K

Related Experiment Videos

Last Updated: Oct 31, 2025

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.8K
A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.2K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.0K

Area of Science:

  • Immunology
  • Molecular Biology
  • Pathology

Background:

  • Prostaglandin E2 (PGE2) is a lipid mediator involved in host immune responses during infections and cancer.
  • Modulating PGE2 levels has been considered for managing the Type I Interferon (IFN) signature in tuberculosis (TB).
  • Limited data exists on the PGE2 pathway's role in active TB patients.

Purpose of the Study:

  • To investigate the immunosuppressive effects of PGE2 on the human host immune response against Mycobacterium tuberculosis (Mtb).
  • To explore the potential of targeting the PGE2 pathway for anti-TB therapeutic strategies.

Main Methods:

  • Culturing human monocytes and neutrophils with Mtb antigens.
  • Assessing the impact of PGE2 on immunological receptor expression, lymphoproliferation, and pro-inflammatory cytokine production.
  • Evaluating PGE2's effect on autophagy in immune cells.

Main Results:

  • PGE2 significantly reduced the expression of immunological receptors on immune cells.
  • PGE2 inhibited lymphoproliferation and decreased the production of pro-inflammatory cytokines.
  • PGE2 enhanced autophagy in monocytes and neutrophils exposed to Mtb antigens.

Conclusions:

  • PGE2 exhibits potent immunosuppressive activity during Mtb infection in humans.
  • PGE2 may attenuate excessive inflammation caused by Mtb, indicating its potential as a therapeutic target.
  • Understanding PGE2's role is crucial for developing improved anti-TB treatments.